Hudson Edge Investment Partners Inc. Buys 36 Shares of The Cigna Group (NYSE:CI)

Hudson Edge Investment Partners Inc. boosted its position in shares of The Cigna Group (NYSE:CI) by 1.9% during the 4th quarter, HoldingsChannel reports. The fund owned 1,883 shares of the health services provider’s stock after buying an additional 36 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in The Cigna Group were worth $520,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC bought a new position in shares of The Cigna Group during the 3rd quarter worth about $37,000. Collier Financial bought a new stake in The Cigna Group in the fourth quarter valued at about $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group in the fourth quarter worth about $34,000. Harbor Capital Advisors Inc. bought a new position in The Cigna Group during the third quarter worth about $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group during the fourth quarter valued at approximately $37,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Raymond James reissued a “strong-buy” rating and issued a $360.00 target price (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Barclays dropped their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Morgan Stanley dropped their target price on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Finally, Royal Bank of Canada cut their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group has an average rating of “Buy” and an average target price of $373.69.

The Cigna Group Stock Up 0.1 %

NYSE:CI opened at $299.92 on Friday. The company has a market cap of $83.42 billion, a price-to-earnings ratio of 24.50, a P/E/G ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The stock’s fifty day moving average price is $286.35 and its two-hundred day moving average price is $319.60. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the business posted $6.79 EPS. On average, analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. The Cigna Group’s payout ratio is currently 45.75%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.